Annual General Meeting of Perbio Science AB

ANNUAL GENERAL MEETING OF PERBIO SCIENCE AB · Caroline Sundewall and CEO Leland G. Foster new members of the Board · Authorisation for the Board to decide on a new share issue At today's Annual General Meeting of Perbio Science AB it was decided that the Board shall consist of seven Board Members, and to re-elect Håkan Björklund, Mats Fischier, Lars Gatenbeck, Jörgen Lönngren and Wilhelm Wendt as Board Members and to elect Caroline Sundewall and CEO Leland G. Foster as new members of the Board. Furthermore, it was decided that remuneration shall be paid at SEK 1,000,000 in total to the Board Members. At the subsequent statutory board meeting, Mats Fischier was elected as Chairman of the Board. The General Meeting approved the proposal submitted by the Board of Directors, thereby confirming the dividend of SEK 1.50 per share. Record day will be Tuesday 15th April, 2003. Dividend settlements will be handled by VPC AB (the Swedish Securities Register Centre) and the estimated settlement day will be Tuesday 22nd April, 2003. For the purpose of allowing the Board to supply capital to the company for its future expansion, and to be able to utilise the company's shares as payment for acquisitions, it was decided to authorise the Board, with or without deviation from shareholders' preferential rights, to increase the company's share-capital by issuing a maximum of 3,687,592 new shares, which corresponds to ten percent of the total issued shares in the company as stated on the day of the meeting. The General Meeting also decided to entrust the Chairman of the Board to, in good time before the Annual General Meeting in 2004, convene a nomination committee consisting of three to four members representing a wide range of ownership. The committee's mission is to prepare and present proposals for the election of Board Members and Auditors and the remuneration to them. It was decided that the Chairman of the Board shall act as additional member and convener of the committee and that the committee among its members elects a chairman. The constitution of the committee shall be made public around 1st December the year before such General Meeting at which the propositions of the committee are to be dealt with. The General Meeting further decided to reject Sveriges Aktiesparares Riksförbund's proposition regarding Remuneration and Audit Committees. Further information Leland G Foster, CEO phone +1 435 757 6432 or Claes Wenthzel, Vice President & CFO phone: +46 42 26 90 92 or +46 70 862 01 22 Perbio Science AB is a listed Swedish biotech company with research institutions, pharmaceutical companies and diagnostic companies as its customers. The USA accounts for the bulk of its business. Perbio Science supplies products, systems and services for the study and production of proteins and develops products in the Bioresearch, Cell Culture and Medical Device fields. The group has 1,266 employees and offices in Sweden, the USA and a number of other countries. Its head office is in Helsingborg, Sweden. More information regarding Perbio Science can be found at www.perbio.com ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2003/04/11/20030411BIT00230/wkr0001.doc http://www.waymaker.net/bitonline/2003/04/11/20030411BIT00230/wkr0002.pdf